ILLINOIS UNION INSURANCE COMPANY v. TEVA PHARMACEUTICALS USA, INC. et al
Filing
34
ORDERED THAT DEFENDANT TEVA'S MOTION TO COMPEL ARBITRATION AND FOR FEES AND COSTS (DOCKET NO. 6)IS GRANTED IN PART TO THE EXTENT THAT THE COURT HEREBY COMPELS ARBITRATION IN LONDON AND DENIED IN PART AS TO TEVA'S REQUESTS FOR ATTORNEYS' FEES AND COSTS. SIGNED BY HONORABLE GENE E.K. PRATTER ON 10/11/13. 10/11/13 ENTERED AND COPIES MAILED AND E-MAILED.(rab, )
IN THE UNITED STATES DISTRICT COURT
FOR THE EASTERN DISTRICT OF PENNSYLVANIA
ILLINOIS UNION INSURANCE
COMPANY,
Plaintiff,
v.
TEVA PHARMACEUTICALS USA, INC.,
and TEVA PHARMACEUTICALS
INDUSTRIES LTD.,
Defendants.
:
:
:
:
:
:
:
:
:
:
CIVIL ACTION
No. 13-3869
ORDER
AND NOW, this 11th day of October, 2013, upon consideration of Teva Pharmaceuticals
USA, Inc.’s (“Teva”) Motion to Compel Arbitration and for Fees and Costs (Docket No. 6), both
parties’ submissions relating thereto (Docket Nos. 17, 19, 23, 31 & 32), and oral argument held
on October 1, 2013, IT IS HEREBY ORDERED that Teva’s Motion to Compel Arbitration and
for Fees and Costs is:
1.
GRANTED IN PART, to the extent that the Court hereby COMPELS
ARBITRATION in London pursuant to Condition o of the underlying SRI
Policy (Generic Products Patent Infringement Excess Casualty Insurance Binder,
Policy No. 25631.3.14 (Compl. Ex. D)); and
2.
DENIED IN PART, as to Teva’s requests for attorneys’ fees and costs.
BY THE COURT:
S/Gene E.K. Pratter
GENE E.K. PRATTER
United States District Judge
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?